0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint |  FREE ONLINE FIRST
Xiaoliang Sunney Xie, PhD
JAMA. Published online May 14, 2015. doi:10.1001/jama.2015.5533

Viewpoint |  FREE ONLINE FIRST
Euan A. Ashley, MRCP, DPhil
JAMA. Published online April 30, 2015. doi:10.1001/jama.2015.3595

Viewpoint | 
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. 2015;313(16):1617-1618. doi:10.1001/jama.2015.2571.

Viewpoint | 
Kitchener D. Wilson, MD, PhD; Joseph C. Wu, MD, PhD
JAMA. 2015;313(16):1613-1614. doi:10.1001/jama.2015.1846.

Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(11):1089-1091. doi:10.1001/jama.2015.0957.

Editorial | 
Howard L. McLeod, PharmD
JAMA. 2015;313(8):803-804. doi:10.1001/jama.2015.1086.

Viewpoint | 
Jennifer A. Doudna, PhD
JAMA. 2015;313(8):791-792. doi:10.1001/jama.2015.287.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(1):19. doi:10.1001/jama.2014.7647.

Original Investigation |  FREE
Andrew X. Zhu, MD, PhD; Masatoshi Kudo, MD, PhD; Eric Assenat, MD, PhD; et al.
JAMA. 2014;312(1):57-67. doi:10.1001/jama.2014.7189.
Includes: Supplemental Content

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(24):2473. doi:10.1001/jama.2014.7360.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
Broad Applicability of Nivolumab in Melanoma Regardless of BRAF Mutation Status
Tara C. Gangadhar, MD; Lynn M. Schuchter, MD
JAMA Oncology
Original Investigation  | 
Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma:  A Pooled Analysis of 4 Clinical Trials
James Larkin, MD, PhD; Christopher D. Lao, MD, MPH; Walter J. Urba, MD, PhD; et al.
JAMA Oncology
Research Letter  | 
Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor:  Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain
Helena A. Yu, MD; Shaozhou K. Tian, MD; Alexander E. Drilon, MD; et al.
JAMA Oncology
Review  | 
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era
Chadi Nabhan, MD; Gordana Raca, MD, PhD; Y. Lynn Wang, MD, PhD